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Background: Blood oxygen saturation (BOS) is decreased in a low-compliant, overactive obstructed bladder. The
objective of this study is to determine the effect of Sildenafil (SC) on bladder function and BOS) in an in vivo animal
model of bladder outlet obstruction.
Methods: Thirty-two guinea pigs; sham operated (n = 8), sham operated + SC (n = 8), urethrally obstructed (n = 8)
and urethrally obstructed + SC (n = 8) were studied during an 8 week period. BOS of the bladder wall was
measured by differential path-length spectroscopy (DPS) before obstruction, at day 0, and at week 8. The bladder
function was evaluated by urodynamic studies every week.
Results: Before surgery and after sham operation all study parameters were comparable. After sham operation,
bladder function and BOS did not change. In the obstructed group the urodynamic parameters were deteriorated
and BOS was decreased. In the group obstruction + SC, bladder compliance remained normal and overactivity
occurred only sporadic. BOS remained unchanged compared to the sham group and was significantly higher
compared to the obstruction group.
Conclusions: In an obstructed bladder the loss of bladder function is accompanied by a significant decrease in
BOS. Treatment of obstructed bladders with SC yields a situation of high saturation, high bladder compliance and
almost no overactivity. Maintaining the microcirculation of the bladder wall might result in better bladder
performance without significant loss of bladder function. Measurement of BOS and interventions focussing on
tissue microcirculation may have a place in the evaluation / treatment of various bladder dysfunctions.
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There is growing evidence that ischemia of the bladder
wall contributes to the initiation of bladder dysfunction.
Several studies have shown effects in obstructed bladder
that can be interpreted as long term results of hypoxia [1].
Furthermore, there is an increasing interest in the nitric
oxide (NO) pathway as a potential pharmacological target
to treat lower urinary tract symptoms.
Phosphodiesterase 5 (PDE5) is involved in the NO path-
way and it has been immunolocalized both in the detrusor
muscle cells and in the vascular endothelium [2]. PDE5 in-
hibitors were found to improve several functional aspects* Correspondence: j.scheepe@erasmusmc.nl
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[2-10]. The mechanisms behind this have not been fully
elucidated yet, but it can be assumed that PDE5 inhibitors
influence detrusor muscle cell action directly but also
indirectly through enhancement of tissue microcircula-
tion of the bladder tissue [11]. In a previous study we
have shown in a Guinea pig model of bladder outlet ob-
struction (BOO) that the oxygen saturation is signifi-
cantly lower in the obstructed bladder compared to
sham operated bladder, both during the voiding and
filling phase [12].
The objective of this study is to investigate the effect
of the PDE5 inhibitor Sildenafil citrate (SC), which en-
hances tissue microcirculation, on bladder function and
blood oxygen saturation (BOS) in vivo in an animal
model of bladder outlet obstruction.l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Animals and study design
Animal experiments were approved by the Erasmus
Medical Center animal ethics committee. Furthermore,
the experiments were conducted according to the AR-
RIVE guidelines.
Thirty-two immature male albino Guinea pigs (Hartley
strain) weighing approximately 250 g were used. Sixteen
animals were urethrally obstructed and 8 of them re-
ceived daily s.c. injections with sildenafil citrate (SC)
(10 mg/kg b.w./day). The other 8 animals received saline
only. Another group of 16 animals were sham operated
and also divided into two groups: plus SC (n = 8) and
plus saline (n = 8). All 32 animals were followed for
8 weeks. Urodynamic investigations were performed be-
fore surgery and at weeks 2,3,4,5,6,7 and 8. DPS mea-
surements were performed at day 0 before surgery (n =
32) and 8 weeks after sham operation (n = 16) or ob-
struction (n = 16).
Experimental model, surgical procedures and DPS
measurements
The Guinea pig model for partial bladder outlet obstruc-
tion (BOO) as described by Kok and Wolffenbuttel et al.
[13,14] was used.
Obstruction and sham operation were done using
ketamine/xylazine anesthesia. The peritoneal cavity was
accessed via a lower vertical midline abdominal incision.
A silver jeweler jump ring with an internal diameter of
2.2 mm was placed around the bladder neck above the
prostate and left there (obstructed group) or removed
(sham operated group). A glass fiber probe was then
placed directly on the body of the bladder for BOS mea-
surements. At the day of sacrifice a similar midline inci-
sion was made to allow probe access to measure BOS of
the bladder wall, as described below, during multiple fill-
ing/voiding cycles. Intravesical pressure was measured
simultaneously. The flow rate was not measured during
DPS measurements but each DPS measurement se-
quence was preceded by a complete urodynamic investi-
gation, including flow rate measurement. After the final
DPS measurement the animal was sacrificed and the
bladder was removed en bloc in order to determine the
bladder weight.
Urodynamics
Urodynamic investigations were performed at week 0 (be-
fore the obstruction/sham operation and first DPS meas-
urement sequence), week 2, 3, 4, 5, 6, 7 and at week 8
(before the second DPS measurement sequence). For each
measurement the animals were anesthetized using keta-
mine (43 mg/kg i.m.) and xylazine (0.9 mg/kg i.m.).
Through a 24-gauge suprapubic catheter bladder pressure
was measured and the bladder was filled continuouslywith sterile saline at a rate of 0.23 ml per minute. Flow
rate was measured with an ultrasound transducer (T106
small animal Flow meter, Transonic Systems, Ithaca, NY)
around the penis.
From the urodynamic data we calculated:
– 1) Number of overactive contractions (NOC):
Number of overactive contractions (>10 cm H2O)
that occur during 1 filling cycle. The average NOC
of all cycles during 1 urodynamic investigation is
reported.
– 2) Maximum voiding pressure (Pmax in cm H2O):
Average Pmax of all voids during 1 urodynamic
investigation is reported.
– 3) Contractility (Wmax in W/m
2): Relation between
pressure and flow during a voiding according to
Griffiths et al. [15]. The average Wmax for all
voidings during 1 urodynamic investigation is
reported.
– 4) The maximal flow rate (Qmax in ml/sec): Highest
absolute value of the flow during voiding.
– 5) Bladder compliance (ml/cm H2O) was defined as
the relationship between change in bladder volume
and the change in bladder pressure in the filling
phase. Care was taken that pressure values obtained
during these periods were not influenced by a
nearby voiding or overactive contraction.Differential path-length spectroscopy (DPS)
Blood oxygenation of the bladder wall was measured
in vivo by differential path-length spectroscopy (DPS)
using glass-fibers at the 2 time points where the bladder
was accessible. During concomitant bladder pressure
measurement the probe was placed in gentle contact
with the serosal surface of the anterior bladder wall. To
avoid artefacts caused by pressing the probe too hard to
the bladder wall the probe was regularly repositioned.
The experimental setup used for DPS measurements
and the DPS data analysis routine was previously de-
scribed in detail by Amelink et al. [16,17]. Complete ses-
sions consisted of a few hundred to more then a thousand
single DPS measurements. During voiding, up to 10 DPS
measurements and during filling, up to hundreds of DPS
measurements could be performed. The average satur-
ation was calculated when at least 5 measurement points
were available.Statistics
We tested the significance of changes at the 2 time
points in the obstructed and sham operated groups with
the paired Student t test. Differences between the
obstructed and sham operated groups were tested with
the unpaired Student t test.
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Loss of animals
Two animals from the obstruction group with saline devel-
oped bladder stones and had to be removed from the study.
In all SC treated animals the urodynamic investigation at
week 5 was not performed due to organizational problems.
Urodynamic data and BOS before operation
Before obstruction or sham operation there were no sta-
tistically significant differences between the 4 groups con-
cerning contractility (±3 W/m2), overactivity (no unstable
contractions) and maximum voiding pressure (<30 cm
H2O) (Figures 1, 2 and 3). The average value for bladder
compliance was higher in the two SC treated groups but
this difference was not significant (Figure 4). Flow rate
was comparable in all 4 groups (data not shown).
The BOS of the bladder during filling averaged be-
tween 92% and 95% in the four groups (Figure 5). The
complete range was moved slightly to higher values in
the two SC treated groups but all differences between
the groups were not statistically significant. During void-
ing the average BOS ranged from 84% to 94% in the 4
groups. The individual BOS values showed more vari-
ation, ranging from 62% to 98% (Figure 5).
Urodynamic data and BOS after sham operation
In both the sham + saline and sham+ SC group the max-
imum voiding pressure, compliance, contractility and over-
activity did not change during the 8 week follow-up. A few
unstable contractions were found in some animals from
both groups at weeks 4 and 8. No differences were found
between both groups except for a statistically significant in-
crease in contractility at week 8 in the sham + SC group
(Figure 1). At week 8 BOS was comparable between both
groups and unchanged from the values at day 0 (Figure 6).0
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Figure 1 Bladder contractility during the 8 week period. *significance
obstruction, *significance of difference versus sham + sildenafil.Urodynamic data and BOS after obstruction
In the obstruction + saline group bladder compliance
was significantly lower compared to both day 0 and to
the corresponding value in the sham + saline group from
week 2 up until week 8. Maximum voiding pressure in-
creased compared to day 0 and to the sham + saline
group, reaching significance at weeks 3,4,6,7 and 8. Blad-
der overactivity was present from week 2 onwards. Blad-
der contractility was higher compared to day 0 and to
the sham + saline group, reaching significance at weeks
2,3,6,7 and 8. The average value for BOS decreased sig-
nificantly both in the filling and voiding phase. The
lower limit of individual voids was 12% (Figure 6).
In the obstruction + SC group compliance remained
comparable to the values at day 0 and to the values in
both sham groups. Compared to the obstruction + saline
group the compliance was significantly higher at weeks
2,3,6,7 and 8. The maximum voiding pressure was similar
to the obstruction + saline group and significantly higher
compared to day 0 and to the sham groups. Contractility
was increased significantly compared to day 0 and to both
sham groups and even compared to the obstruction + sa-
line group (weeks 3,4,6,7 and 8). Overactivity was found
throughout the 8 week follow-up but was significantly
lower as compared to the obstruction + saline group.
BOS did not decrease in the obstruction + SC group
after 8 weeks of obstruction. It was significantly higher
compared to the obstruction + saline group. The lowest
individual value was 71% (Figure 6).
Bladder weight
The average bladder weights of the sham+ saline group
and obstruction + saline group was 0.75 ± 0.07. and 1.64 ±
0.36 grams, respectively (p < 0.04). Treatment of the
obstructed animals with SC resulted in a significant lesserSham + SC Obstruction + SC
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Figure 2 Bladder over-activity during the 8 week period. #significance of difference vs sham, p < 0.05, & significance of difference vs
obstruction, *significance of difference versus sham + sildenafil.
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weight of the sham+ SC group was lower (0.55 ± 0.03)
compared to the sham+ saline group.
Discussion
During bladder filling the saturation in the normal Guinea
pig bladder is around 90%. At the end of bladder filling
and during voiding there is a marked decrease in satur-
ation. Shortly after voiding the saturation returns to its
high pre-voiding value.
The obstructed bladder is characterized by a signifi-
cantly lower saturation both during voiding and filling.
This decrease in saturation is more pronounced when
detrusor overactivity occurs during the filling phase [12].
In contrast, in Guinea pigs with BOO treated with SC
the bladder saturation both during filling and voidingSham Obstruction
0
10
20
30
40
50
60
70
80
90
0 8 0 82 2
Pm
ac
, c
m
 H
2O
#
#
#
#
#
Figure 3 Maximum voiding pressure during the 8 week period. #signi
obstruction, *significance of difference versus sham + sildenafil.remains as high as in the sham operated animals. This
maintenance of a high saturation level is accompanied by
normal bladder compliance and less overactivity. Main-
taining bladder compliance and damping detrusor over-
activity might be explained by direct smooth muscle cell
action of the PDE5 inhibitor SC. However, the maximum
voiding pressure and the contractility of SC-treated
obstructed bladder increase at least as much as in the sa-
line treated obstructed bladder. This phenomenon can not
be explained by a direct muscle relaxing effect of SC
alone. Possibly the maintenance of an almost normal blad-
der function in animals with BOO treated with SC is an
effect of enhanced bladder microcirculation rather then a
direct effect on muscle cells. Obstructed bladders treated
with SC have a higher saturation level.. Muscle cells acting
aerobically can produce force more efficiently than theSham + SC Obstruction + SC
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Figure 4 Bladder compliance during the 8 week period. #significance of difference vs sham, p < 0.05, & significance of difference vs
obstruction, *significance of difference versus sham + sildenafil.
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circumstances. As a consequence, the increased con-
tractility and voiding pressure that are needed to over-
come the obstruction need less muscle mass and the
bladder wall increases less in size resulting in less
muscle hypertrophy. This may partly explain the better
compliance and the lower bladder weight that was ob-
served in the SC treated obstructed bladder. Low satur-
ation may excite nerve endings in the bladder wall,
leading to overactivity and higher muscle tone. Main-
tenance of a high saturation could prevent this nerve
action and may result in better bladder compliance. In
support of this is our finding that SC treated obstructed
bladder shows less overactivity.
Similar effects of PDE5 inhibitors on bladder function
have been found with in vitro muscle strip tests in a rat
model of BOO [18,19]. The carbachol induced con-
tractile force of bladder strips tested in vitro is reduced
by BOO. Vardenafil treatment during the obstructive
period diminishes this in vitro loss of carbachol in-
duced contractility [18]. Muscle strips from sham oper-
ated rats that received vardenafil showed an increased
contractility as compared to normal rat bladder strips0 20 40 60 80 100
Filling, sham
Filling, obstruction
Filling, sham+SC
Filling, obstruction+SC
Voiding, sham
Voiding, obstruction
Voiding, sham+SC
 Voiding, obstruction+SC
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Figure 5 The % saturation during filling and voiding before
sham/obstructive surgery. The bars represent the lowest, highest
and average value.[19]. In our experiments, we noticed a trend for in-
creased contractility of the whole bladder in the silden-
afil treated sham operated animals but this was only
significant at week 8. This might be explained by a
slight increase of bladder saturation during detrusor
contraction. Furthermore, in the sildenafil treated sham
operated animals the bladder weight was lower com-
pared to sham + saline group. Thus, possibly the unob-
structed bladder also benefits from optimal saturation.
In our experimental setup we did not determine a tissue
marker for hypoxia such as glycogen or hypoxia-inducible
factor 1 (HIF-1). In a previous study we demonstrated that
the presence of glycogen deposits in the bladder wall cor-
relates well with loss of bladder function in both Guinea
pigs and humans [20,21]. Furthermore, we demonstrated
in another study [12] that the glycogen content of the
bladder wall was increased in obstructed Guinea pigs in
comparison with sham operated animals. The same study
revealed a good correlation between DPS measurements
and glycogen deposits in the bladder wall. Therefore, we
did not expect any further relevant information from tis-
sue markers in this experimental setup and determination
of glycogen deposits were not done on a regular basis.50 60 70 80 90 100
Filling , before sham
Filling, before obstruction
FIlling, before sham+SC
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Figure 6 The % saturation during filling and voiding 8 weeks
after sham/obstructive surgery. The bars represent the lowest,
highest and average value.
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in the initiation and progression of voiding dysfunction
[1]. Although the data are preliminary, they correlate
with a mechanism where bladder dysfunction in BOO is
initiated by bladder pressure related ischemia and reper-
fusion injury. With the present model it is not obvious if
the effect is just a matter of better flow due to vessels
smooth muscle relaxation or due to preservation of mi-
crovasculature or stimulation of angiogenesis. Future ex-
periments with DPS-measurements of blood volume per
cross-sectional area and measurements of vessel diame-
ters might answer these questions.
The mechanism of increased pressure and overactivity
reducing saturation that in turn reduces bladder func-
tion by impeding aerobic muscle action and by excita-
tion of bladder nerves poses a self enhancing loop.
Direct actions on the saturation part in this loop like
with the PDE5 inhibitor sildenafil citrate used here may
disrupt this loop and thereby might prevent the loss of
bladder function that otherwise occurs.Conclusions
In a normal bladder BOS is high in the filling phase and
drops slightly during voiding. In an obstructed bladder
the loss of bladder function is accompanied by a signifi-
cant decrease in BOS during voiding and filling. Treat-
ment of obstructed bladders with SC maintains normal
BOS during filling and voiding resulting in high bladder
compliance and less DO. This supports the hypothesis
that maintaining the microcirculation of the bladder wall
results in better bladder performance without signifi-
cant loss of bladder function. Measurement of BOS and
interventions focussing on tissue microcirculation may
have a place in the evaluation/treatment of various blad-
der dysfunctions.
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